strong start next investor
day may reiter buy
broad-bas strength lead better expect quarter
baxter deliv sale growth high end guidanc lead
earn beat guidanc rais strength broad-bas
particularli strong growth renal care acut therapi advanc surgeri
inject pharmaceut result provid baxter good momentum
head particularli head compani may investor
day view investor day next catalyst believ investor leav
better appreci baxter long-term growth stori reiter
buy rate price target
guidanc rais reect strength continu posit outlook
second quarter compani expect sale growth approxim
constant currenc growth oper basi dilut ep
guidanc set bracket street estim
full year manag expect constant currenc growth
oper basi versu prior guidanc constant currenc
oper manag also expect ep around vs prior
current consensu estim rais
ep estim ep estim
recent new product launch drive growth
quarter baxter close acquisit recothrom preveleak
two product expect add
approxim million sale compani advanc surgeri segment
baxter also launch tisseel prima sealant europ bolster
organ growth within advanc surgeri segment
within renal baxter launch kaguya periton dialysi pd system
japan march japanes pd market larg gone untap larg due
concern around periton contamin kaguya system includ
automat assembl function connect tube cathet
kaguya launch provid compani sustain growth engin
given limit market penetr date
price apr usd
distribut gmt
deutsch bank seek busi compani cover research report thu investor
awar rm may conict interest could aect object report investor consid
report singl factor make invest decis disclosur analyst certif
within medic deliveri compani expect launch version nine
spectrum infus pump us market note help
boost growth
view investor day next catalyst
may manag plan host analyst meet review pipelin
provid updat long-rang plan expect manag rais
target given strong perform provid aspir
believ baxter approach inect point top line perspect
expect growth acceler higher given increas weight
growth area like gener inject improv area like in-cent
hemodialysi contribut new product contribut capit
forecast ratio
result y/i chang oper basi unless note factset
total sale report basi constant currenc
oper oper growth reect follow
renal sale million reect global growth
periton hemodialysi busi
medic deliveri million year year sale
 larg volum iv solut oset lower sale intern
impact hurrican maria
pharmaceut million oper driven
strength inject busi
nutrit million year-over-year growth intern
market oset impact hurrican maria sale
takeawaysvari analysi surpris histori exceptp share product sale trend milrptdex-fxren revenu expect grow report basi constant currenc basi oper ep guidanc rais full year guidanc rang report basi constant currenc basi oper full year ep guidanc revis million factset fs dbe sale report basi constant currenc basi y/i growth driven strong demand renal advanc surgeri product ep y/i well ahead consensu estim guidanc rang rel model beat driven better oper perform overal lesser extent tax rate detail quarter million except per share data chang sale constant currenc basi unless otherwis sale ep ahead street expect compani guidanc rais full year sale ep guidanc changemix ep beat partial due lower tax improv quick total sale constant currenc basi oper neg impact fx lost sale due hurrican maria increment suppli chain increas freight adj margin y/i adj oper margin net interest expens decreas prior adj tax rate reflect million benefit fa stock compens adjust ep ahead fs dbe april
advanc surgeri million oper
acut therapi million reect strength global
demand well benet intens season
million
figur baxter incom statement million except per share amount
baxtertot control net net incom adj operationsreconcili adjust epsamort net adjust april
price current end previou trade session unless otherwis indic sourc local exchang via reuter bloomberg vendor
inform sourc deutsch bank subject compani sourc disclosur pertain recommend estim made secur
primari subject research pleas see recent publish compani report visit global disclosur look-up page websit http //research db com/
research/disclosures/companysearch asid within report import risk conict disclosur also found http //research db com/research/topics/equ
investor strongli encourag review inform invest
import disclosur requir regul
disclosur mark asterisk may also requir least one jurisdict addit unit state see
import disclosur requir non-u regul explanatori note
within past year deutsch bank and/or aliat manag co-manag public privat
oer compani receiv fee
deutsch bank and/or aliat receiv compens compani provis
invest bank nancial advisori servic within past year
deutsch bank and/or aliat expect receiv intend seek compens invest bank
servic compani next three month
deutsch bank and/or aliat receiv non-invest bank relat compens
compani within past year
compani client deutsch bank secur inc within past year time
import disclosur requir non-u regul
